These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8432493

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma levels of haloperidol and clinical response.
    Van Putten T, Marder SR, May PR, Poland RE, O'Brien RP.
    Psychopharmacol Bull; 1985; 21(1):69-72. PubMed ID: 3920705
    [No Abstract] [Full Text] [Related]

  • 3. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical implications of determination of plasma haloperidol levels.
    Santos JL, Cabranes JA, Almoguera I, Ramos JA, Vazquez C, Angeles F.
    Acta Psychiatr Scand; 1989 Apr; 79(4):348-54. PubMed ID: 2735205
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
    D'Souza DC, Bennett A, Abi-Dargham A, Krystal JH.
    J Clin Psychopharmacol; 1994 Oct; 14(5):361-3. PubMed ID: 7806697
    [No Abstract] [Full Text] [Related]

  • 8. Haloperidol dosing requirements: the contribution of smoking and nonlinear pharmacokinetics.
    Perry PJ, Miller DD, Arndt SV, Smith DA, Holman TL.
    J Clin Psychopharmacol; 1993 Feb; 13(1):46-51. PubMed ID: 8486817
    [Abstract] [Full Text] [Related]

  • 9. Plasma drug level and clinical response.
    Cooper TB, Volavka J, Czobor P.
    J Clin Psychopharmacol; 1992 Apr; 12(2):134-6. PubMed ID: 1573036
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients.
    Chang WH, Lin SK, Juang DJ, Chen LC, Yang CH, Lane HY, Jann MW.
    Biol Psychiatry; 1993 Apr 01; 33(7):557-9. PubMed ID: 8513043
    [No Abstract] [Full Text] [Related]

  • 16. The influence of cigarette smoking on haloperidol pharmacokinetics.
    Miller DD, Kelly MW, Perry PJ, Coryell WH.
    Biol Psychiatry; 1990 Sep 15; 28(6):529-31. PubMed ID: 2223923
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K, Higuchi H, Hishikawa Y.
    Clin Neuropharmacol; 1998 Sep 15; 21(1):68-9. PubMed ID: 9579290
    [Abstract] [Full Text] [Related]

  • 19. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 Sep 15; 24(4):165-72. PubMed ID: 8984849
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.